Höcht C - Search Results

1

New and developing pharmacotherapies for hypertension.

Höcht C, Allo MA, Polizio AH, Morettón MA, Carranza A, Chiappetta DA, Choi MR. Höcht C, et al. Expert Rev Cardiovasc Ther. 2022 Aug;20(8):647-666. doi: 10.1080/14779072.2022.2105204. Epub 2022 Aug 3. Expert Rev Cardiovasc Ther. 2022. PMID: 35880547 Review.

2

In vitro/in vivo characterization of melt-molded gabapentin-loaded poly(epsilon-caprolactone) implants for sustained release in animal studies.

Carcaboso AM, Chiappetta DA, Höcht C, Blake MG, Boccia MM, Baratti CM, Sosnik A. Carcaboso AM, et al. Among authors: hocht c. Eur J Pharm Biopharm. 2008 Oct;70(2):666-73. doi: 10.1016/j.ejpb.2008.05.031. Epub 2008 Jun 12. Eur J Pharm Biopharm. 2008. PMID: 18590815

3

Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties.

Taira CA, Carranza A, Mayer M, Di Verniero C, Opezzo JA, Höcht C. Taira CA, et al. Among authors: hocht c. Curr Clin Pharmacol. 2008 Sep;3(3):174-84. doi: 10.2174/157488408785747719. Curr Clin Pharmacol. 2008. PMID: 18781904 Review.

4

Episcleral implants for topotecan delivery to the posterior segment of the eye.

Carcaboso AM, Chiappetta DA, Opezzo JA, Höcht C, Fandiño AC, Croxatto JO, Rubio MC, Sosnik A, Abramson DH, Bramuglia GF, Chantada GL. Carcaboso AM, et al. Among authors: hocht c. Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2126-34. doi: 10.1167/iovs.09-4050. Epub 2009 Oct 15. Invest Ophthalmol Vis Sci. 2010. PMID: 19834044

5

Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].

Chiappetta DA, Hocht C, Taira C, Sosnik A. Chiappetta DA, et al. Among authors: hocht c. Nanomedicine (Lond). 2010 Jan;5(1):11-23. doi: 10.2217/nnm.09.90. Nanomedicine (Lond). 2010. PMID: 20025460

6

Novel long-term anticonvulsant treatment with gabapentin without causing memory impairment in mice.

Blake MG, Boccia MM, Carcaboso AM, Chiappetta DA, Höcht C, Krawczyk MC, Sosnik A, Baratti CM. Blake MG, et al. Among authors: hocht c. Epilepsy Behav. 2010 Feb;17(2):157-64. doi: 10.1016/j.yebeh.2009.12.005. Epub 2010 Jan 15. Epilepsy Behav. 2010. PMID: 20079694

7

A highly concentrated and taste-improved aqueous formulation of efavirenz for a more appropriate pediatric management of the anti-HIV therapy.

Chiappetta DA, Hocht C, Sosnik A. Chiappetta DA, et al. Among authors: hocht c. Curr HIV Res. 2010 Apr;8(3):223-31. doi: 10.2174/157016210791111142. Curr HIV Res. 2010. PMID: 20158456

8

Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension.

Di Verniero CA, Bertera F, Buontempo F, Bernabeu E, Chiappetta D, Mayer MA, Bramuglia GF, Taira CA, Höcht C. Di Verniero CA, et al. Among authors: hocht c. J Pharm Pharmacol. 2010 Jul;62(7):890-900. doi: 10.1211/jpp.62.07.0010. J Pharm Pharmacol. 2010. PMID: 20636877

9

Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles.

Chiappetta DA, Hocht C, Taira C, Sosnik A. Chiappetta DA, et al. Among authors: hocht c. Biomaterials. 2011 Mar;32(9):2379-87. doi: 10.1016/j.biomaterials.2010.11.082. Epub 2010 Dec 24. Biomaterials. 2011. PMID: 21186055

10

Heme oxygenase-1 overexpression fails to attenuate hypertension when the nitric oxide synthase system is not fully operative.

Polizio AH, Santa-Cruz DM, Balestrasse KB, Gironacci MM, Bertera FM, Höcht C, Taira CA, Tomaro ML, Gorzalczany SB. Polizio AH, et al. Among authors: hocht c. Pharmacology. 2011;87(5-6):341-9. doi: 10.1159/000327939. Epub 2011 Jun 3. Pharmacology. 2011. PMID: 21646819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters